ArticleSurgery today2020
Clinical role of serum programmed death ligand 1 in patients with hepatocellular carcinoma: Where does it come from?
Hatem A Elmezayen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it